Adriana Maria Kiędzierska-Mencfeld
age 45Currently 1 role in 1 KRS entity. In the KRS since 2020.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
Polpharma Biologics S.A. |
since Jul 22, 2020 | ul. Trzy Lipy 3, 80-172 Gdańsk |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Share capital reduced | Share capital: PLN 1,833,478,300 → PLN 1,175,432,600 Polpharma Biologics S.A. | Polpharma Biologics S.A. | |
| Share capital reduced | Share capital: PLN 2,013,478,300 → PLN 1,833,478,300 Polpharma Biologics S.A. | Polpharma Biologics S.A. | |
| Share capital increased | Share capital: PLN 1,863,478,300 → PLN 2,013,478,300 Polpharma Biologics S.A. | Polpharma Biologics S.A. | |
| Share capital increased | Share capital: PLN 1,713,478,300 → PLN 1,863,478,300 Polpharma Biologics S.A. | Polpharma Biologics S.A. | |
| Share capital increased | Share capital: PLN 1,463,478,300 → PLN 1,713,478,300 Polpharma Biologics S.A. | Polpharma Biologics S.A. | |
| Share capital increased | Share capital: PLN 1,213,478,300 → PLN 1,463,478,300 Polpharma Biologics S.A. | Polpharma Biologics S.A. | |
| Role changed | Management Board Member → President of the Management Board Polpharma Biologics S.A. | Polpharma Biologics S.A. | |
| Share capital increased | Share capital: PLN 963,478,300 → PLN 1,213,478,300 Polpharma Biologics S.A. | Polpharma Biologics S.A. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Risk signals
| Signal | Details |
|---|---|
Politically exposed person (PEP) | None |
Person on a sanctions list | None |
Bankruptcy or restructuring | None |
Liquidation | None |
Sanctions list | None |
Inactive entity | None |
Connected people
| Person | Shared entity | Period | |
|---|---|---|---|
Andrzej Uzdrowskiage 44 | Polpharma Biologics S.A. | since Jan 7, 2026 | |
Polpharma Biologics S.A. | since Nov 27, 2024 | ||
Polpharma Biologics S.A. | since Nov 27, 2024 | ||
Monika Głowacka-Różańskaage 46 | Polpharma Biologics S.A. | since Feb 13, 2026 |